8-20220382-C-T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1_ModeratePM2PP5_Very_Strong
The NM_001693.4(ATP6V1B2):c.1516C>T(p.Arg506*) variant causes a stop gained change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_001693.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ATP6V1B2 | NM_001693.4 | c.1516C>T | p.Arg506* | stop_gained | Exon 14 of 14 | ENST00000276390.7 | NP_001684.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ATP6V1B2 | ENST00000276390.7 | c.1516C>T | p.Arg506* | stop_gained | Exon 14 of 14 | 1 | NM_001693.4 | ENSP00000276390.2 | ||
ATP6V1B2 | ENST00000523482.5 | n.5600C>T | non_coding_transcript_exon_variant | Exon 11 of 11 | 2 | |||||
ATP6V1B2 | ENST00000521442.1 | n.100+2100C>T | intron_variant | Intron 1 of 3 | 3 | ENSP00000430866.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 30
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Autosomal dominant deafness - onychodystrophy syndrome Pathogenic:2
Based on the classification scheme VCGS_Germline_v1.1.1, this variant is classified as Pathogenic. Following criteria are met: 0102 - Loss-of-function has been shown to be a mechanism of disease for this gene (PMID: 24913193). (N) 0107 - This gene is known to be associated with autosomal dominant disease. (N) 0205 - Variant is predicted to result in a truncated protein with less than 1/3 of the protein affected (exon 14 of 14). (P) 0251 - Variant is heterozygous. (N) 0301 - Variant is absent from gnomAD. (P) 0604 - Variant is not located in an established domain, motif, hotspot or informative constraint region. (N) 0705 - No comparable variants have previous evidence for pathogenicity. Other truncating variants downstream of this variant has not been reported (ClinVar, PMID: 31655144). (N) 0801 - Strong previous evidence of pathogenicity in unrelated individuals where variant has been shown to be de novo. (ClinVar, PMID: 24913193, 28396750, 31581539). (P) 1002 - Moderate functional evidence supporting abnormal protein function, with variant shown to result in reduced ATPase hydrolysis activity (PMID: 24913193). (P) 1208 - Inheritance information for this variant is not currently available. (N) Legend: (P) - Pathogenic, (N) - Neutral, (B) - Benign -
- -
Neurodevelopmental delay Pathogenic:1
- -
not provided Pathogenic:1
Published functional studies demonstrate a damaging effect; ATPase hydrolysis activity was decreased in cells expressing the R506* variant, and a knock-in mouse model incorporating R506* showed changes in brain composition compared to wild type mice (Yuan et al., 2014; Zhao et al., 2019); Nonsense variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is not a known mechanism of disease; Not observed at significant frequency in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 28396750, 34912366, 32849222, 31257146, 32961450, 24913193, 32873933) -
Autosomal dominant deafness - onychodystrophy syndrome;C4225321:Zimmermann-Laband syndrome 2 Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at